NCT02858804 2026-02-11BDH-MCL01Institute of Hematology & Blood Diseases Hospital, ChinaPhase 4 Completed55 enrolled
NCT03710772 2026-02-11Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell LymphomaM.D. Anderson Cancer CenterPhase 2 Active not recruiting51 enrolled